Applying Recent Data to Your Everyday Practice in Biliary Tract Cancers

Are you using the best approach for patients with HER2-positive biliary tract cancer (BTC)? Credit available for this activity expires: 4/30/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002492?ecd=bdc_podcast_libsyn_mscpedu